Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma
Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adju...
Gespeichert in:
Veröffentlicht in: | Archives of orthopaedic and trauma surgery 1998, Vol.117 (1-2), p.43-46 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 46 |
---|---|
container_issue | 1-2 |
container_start_page | 43 |
container_title | Archives of orthopaedic and trauma surgery |
container_volume | 117 |
creator | QUINT, U MÜLLER, R. T MÜLLER, G |
description | Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adjuvant therapy involving irrigation of the remaining bone cavity with phenol can distinctly decrease the rate of relapse. Little is known about the amount of phenol applied that is absorbed. This study investigated the urinary excretion of phenol following the instillation of 102 ml of a 5% phenol solution. The method consisted of urine collection from 11 patients treated by phenol instillation preoperatively, and at 1, 3, 6, 12 and 24 h postoperatively. The urine specimens were analysed for phenol by mass spectrometry. Preoperatively, the value was 5.1 mg/l on average. The maximum concentration of 62 mg/l was found 1 h after instillation, with an average value of 41.5 mg/l, and after 3 h of 18.9 mg/l. A further rapid decrease in the excretion rate was recorded, with normal values being reached after 12 h. This means a maximum of 9% and an average of 2% of the instilled amount of phenol were excreted in the urine within 24 h postoperatively. By comparing these urinary concentrations to published standards, we conclude that the instillation of a 5% phenol solution into bony lesions is associated with a relatively low risk of systemic toxicity. |
doi_str_mv | 10.1007/BF00703438 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00703438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9457335</sourcerecordid><originalsourceid>FETCH-LOGICAL-c202t-a794e2d6510d4205e09c6b33b484a4b1c93de619460c50d5279d8352d96dbf1c3</originalsourceid><addsrcrecordid>eNpFkE1LxDAQhoMo67p68S7k4EmsTj7beNPFj4UFL3ouaZKylbRZki6ov96WLSsMM7wzzwzMi9AlgTsCkN8_vQwZGGfFEZoTznjGFJHHaA6KyawAQU7RWUpfAIQWCmZoprjIGRNz9Lvc6KhN72KT-sYkHGq83bguePyAV93Q8173TehwM0YftXdpkNrjfteGiN23acbGuGg2obMxVF6nPrT6FofUu2AmiXVnsesmqNXn6KTWPrmLqS7Q58vzx_ItW7-_rpaP68xQoH2mc8UdtVIQsJyCcKCMrBireME1r4hRzDpJFJdgBFhBc2ULJqhV0lY1MWyBbvZ3TQwpRVeX29i0Ov6UBMrRv_LfvwG-2sPbXdU6e0Anw4b59TTXyWhfR90N_x8wCnnOZM7-AOgseVU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>QUINT, U ; MÜLLER, R. T ; MÜLLER, G</creator><creatorcontrib>QUINT, U ; MÜLLER, R. T ; MÜLLER, G</creatorcontrib><description>Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adjuvant therapy involving irrigation of the remaining bone cavity with phenol can distinctly decrease the rate of relapse. Little is known about the amount of phenol applied that is absorbed. This study investigated the urinary excretion of phenol following the instillation of 102 ml of a 5% phenol solution. The method consisted of urine collection from 11 patients treated by phenol instillation preoperatively, and at 1, 3, 6, 12 and 24 h postoperatively. The urine specimens were analysed for phenol by mass spectrometry. Preoperatively, the value was 5.1 mg/l on average. The maximum concentration of 62 mg/l was found 1 h after instillation, with an average value of 41.5 mg/l, and after 3 h of 18.9 mg/l. A further rapid decrease in the excretion rate was recorded, with normal values being reached after 12 h. This means a maximum of 9% and an average of 2% of the instilled amount of phenol were excreted in the urine within 24 h postoperatively. By comparing these urinary concentrations to published standards, we conclude that the instillation of a 5% phenol solution into bony lesions is associated with a relatively low risk of systemic toxicity.</description><identifier>ISSN: 0936-8051</identifier><identifier>EISSN: 1434-3916</identifier><identifier>DOI: 10.1007/BF00703438</identifier><identifier>PMID: 9457335</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Adult ; Biological and medical sciences ; Bone Neoplasms - surgery ; Bones, joints and connective tissue. Antiinflammatory agents ; Chondroblastoma - surgery ; Chondroma - surgery ; Combined Modality Therapy ; Female ; Giant Cell Tumor of Bone - surgery ; Humans ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Phenol - administration & dosage ; Phenol - pharmacokinetics ; Phenol - urine ; Prospective Studies ; Therapeutic Irrigation</subject><ispartof>Archives of orthopaedic and trauma surgery, 1998, Vol.117 (1-2), p.43-46</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c202t-a794e2d6510d4205e09c6b33b484a4b1c93de619460c50d5279d8352d96dbf1c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2077367$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9457335$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>QUINT, U</creatorcontrib><creatorcontrib>MÜLLER, R. T</creatorcontrib><creatorcontrib>MÜLLER, G</creatorcontrib><title>Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma</title><title>Archives of orthopaedic and trauma surgery</title><addtitle>Arch Orthop Trauma Surg</addtitle><description>Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adjuvant therapy involving irrigation of the remaining bone cavity with phenol can distinctly decrease the rate of relapse. Little is known about the amount of phenol applied that is absorbed. This study investigated the urinary excretion of phenol following the instillation of 102 ml of a 5% phenol solution. The method consisted of urine collection from 11 patients treated by phenol instillation preoperatively, and at 1, 3, 6, 12 and 24 h postoperatively. The urine specimens were analysed for phenol by mass spectrometry. Preoperatively, the value was 5.1 mg/l on average. The maximum concentration of 62 mg/l was found 1 h after instillation, with an average value of 41.5 mg/l, and after 3 h of 18.9 mg/l. A further rapid decrease in the excretion rate was recorded, with normal values being reached after 12 h. This means a maximum of 9% and an average of 2% of the instilled amount of phenol were excreted in the urine within 24 h postoperatively. By comparing these urinary concentrations to published standards, we conclude that the instillation of a 5% phenol solution into bony lesions is associated with a relatively low risk of systemic toxicity.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bone Neoplasms - surgery</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Chondroblastoma - surgery</subject><subject>Chondroma - surgery</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Giant Cell Tumor of Bone - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenol - administration & dosage</subject><subject>Phenol - pharmacokinetics</subject><subject>Phenol - urine</subject><subject>Prospective Studies</subject><subject>Therapeutic Irrigation</subject><issn>0936-8051</issn><issn>1434-3916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LxDAQhoMo67p68S7k4EmsTj7beNPFj4UFL3ouaZKylbRZki6ov96WLSsMM7wzzwzMi9AlgTsCkN8_vQwZGGfFEZoTznjGFJHHaA6KyawAQU7RWUpfAIQWCmZoprjIGRNz9Lvc6KhN72KT-sYkHGq83bguePyAV93Q8173TehwM0YftXdpkNrjfteGiN23acbGuGg2obMxVF6nPrT6FofUu2AmiXVnsesmqNXn6KTWPrmLqS7Q58vzx_ItW7-_rpaP68xQoH2mc8UdtVIQsJyCcKCMrBireME1r4hRzDpJFJdgBFhBc2ULJqhV0lY1MWyBbvZ3TQwpRVeX29i0Ov6UBMrRv_LfvwG-2sPbXdU6e0Anw4b59TTXyWhfR90N_x8wCnnOZM7-AOgseVU</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>QUINT, U</creator><creator>MÜLLER, R. T</creator><creator>MÜLLER, G</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1998</creationdate><title>Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma</title><author>QUINT, U ; MÜLLER, R. T ; MÜLLER, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c202t-a794e2d6510d4205e09c6b33b484a4b1c93de619460c50d5279d8352d96dbf1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bone Neoplasms - surgery</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Chondroblastoma - surgery</topic><topic>Chondroma - surgery</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Giant Cell Tumor of Bone - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenol - administration & dosage</topic><topic>Phenol - pharmacokinetics</topic><topic>Phenol - urine</topic><topic>Prospective Studies</topic><topic>Therapeutic Irrigation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>QUINT, U</creatorcontrib><creatorcontrib>MÜLLER, R. T</creatorcontrib><creatorcontrib>MÜLLER, G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Archives of orthopaedic and trauma surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>QUINT, U</au><au>MÜLLER, R. T</au><au>MÜLLER, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma</atitle><jtitle>Archives of orthopaedic and trauma surgery</jtitle><addtitle>Arch Orthop Trauma Surg</addtitle><date>1998</date><risdate>1998</risdate><volume>117</volume><issue>1-2</issue><spage>43</spage><epage>46</epage><pages>43-46</pages><issn>0936-8051</issn><eissn>1434-3916</eissn><abstract>Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adjuvant therapy involving irrigation of the remaining bone cavity with phenol can distinctly decrease the rate of relapse. Little is known about the amount of phenol applied that is absorbed. This study investigated the urinary excretion of phenol following the instillation of 102 ml of a 5% phenol solution. The method consisted of urine collection from 11 patients treated by phenol instillation preoperatively, and at 1, 3, 6, 12 and 24 h postoperatively. The urine specimens were analysed for phenol by mass spectrometry. Preoperatively, the value was 5.1 mg/l on average. The maximum concentration of 62 mg/l was found 1 h after instillation, with an average value of 41.5 mg/l, and after 3 h of 18.9 mg/l. A further rapid decrease in the excretion rate was recorded, with normal values being reached after 12 h. This means a maximum of 9% and an average of 2% of the instilled amount of phenol were excreted in the urine within 24 h postoperatively. By comparing these urinary concentrations to published standards, we conclude that the instillation of a 5% phenol solution into bony lesions is associated with a relatively low risk of systemic toxicity.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>9457335</pmid><doi>10.1007/BF00703438</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0936-8051 |
ispartof | Archives of orthopaedic and trauma surgery, 1998, Vol.117 (1-2), p.43-46 |
issn | 0936-8051 1434-3916 |
language | eng |
recordid | cdi_crossref_primary_10_1007_BF00703438 |
source | MEDLINE; SpringerNature Journals |
subjects | Adult Biological and medical sciences Bone Neoplasms - surgery Bones, joints and connective tissue. Antiinflammatory agents Chondroblastoma - surgery Chondroma - surgery Combined Modality Therapy Female Giant Cell Tumor of Bone - surgery Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Phenol - administration & dosage Phenol - pharmacokinetics Phenol - urine Prospective Studies Therapeutic Irrigation |
title | Characteristics of phenol : Instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T23%3A46%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20of%20phenol%20:%20Instillation%20in%20intralesional%20tumor%20excision%20of%20chondroblastoma,%20osteoclastoma%20and%20enchondroma&rft.jtitle=Archives%20of%20orthopaedic%20and%20trauma%20surgery&rft.au=QUINT,%20U&rft.date=1998&rft.volume=117&rft.issue=1-2&rft.spage=43&rft.epage=46&rft.pages=43-46&rft.issn=0936-8051&rft.eissn=1434-3916&rft_id=info:doi/10.1007/BF00703438&rft_dat=%3Cpubmed_cross%3E9457335%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/9457335&rfr_iscdi=true |